Skip to main content

Table 4 Sensitivity analysis (sample size ≥ 90)

From: Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials

Outcome

No. of studies

Pooled sample size

Heterogeneity

Overall effect

 

T2

I2

P-value

SMD [95% CI]

P-value

BMI

4

605

0.05

65%

0.03

0.21 [-0.06, 0.49]

0.13

FPG

8

1228

0.01

30%

0.18

0.09 [-0.04, 0.23]

0.18

HbA1c

8

1228

0.03

56%

0.03

0.06 [-0.12, 0.23]

0.52

PPBS

6

792

0.00

0%

0.59

-0.01 [-0.15, 0.13]

0.85

TC

3

504

0.22

90%

<0.0001

0.56 [0.00, 1.12]

0.05

HDL

3

504

0.18

88%

0.0002

-0.27 [-0.78, 0.24]

0.30

LDL

3

504

0.01

21%

0.28

0.41 [0.21, 0.61]

<0.0001

TG

3

504

0.00

0%

0.61

0.13 [-0.05, 0.30]

0.16

FINS

5

698

0.44

93%

<0.00001

0.37 [-0.23, 0.98]

0.22